9 results on '"Anthuber, Matthias"'
Search Results
2. Tumor proportion in colon cancer: results from a semiautomatic image analysis approach.
- Author
-
Martin B, Banner BM, Schäfer EM, Mayr P, Anthuber M, Schenkirsch G, and Märkl B
- Subjects
- Adult, Aged, Aged, 80 and over, Colonic Neoplasms diagnosis, Disease-Free Survival, Female, Humans, Male, Middle Aged, Prognosis, Proportional Hazards Models, Survival Rate, Adenocarcinoma pathology, Colonic Neoplasms pathology, Lymphatic Metastasis pathology, Stromal Cells pathology
- Abstract
The tumor stroma ratio (TSR) is a promising prognostic biomarker in colon cancer, which could provide additional risk stratification for therapy adaption. The objective of our study was the investigation of the prognostic significance of TSR at different tumor sites in a simple semiautomatic approach with the open-source program ImageJ. We investigated 206 pT3 and pT4 adenocarcinomas of no special type. According to our established thresholds, 31 tumors (15%) were classified as low tumor proportion (TP) (≤ 15% TP), 42 tumors (20%) were classified as high TP (≥ 54% TP), and 133 tumors (65%) were classified as medium TP. High and low TP were associated with an adverse overall survival in comparison to medium TP (p = 0.001 and p = 0.03). Furthermore, the TP was an independent risk factor of occurrence of distant metastasis next to T status, microsatellite status, and tumor budding. The 5-year survival rate was 49% in patients with high TP, 48% in patients with low TP, and 68% in patients with medium TP (p = 0.042, n = 160). Patients with a high TP had less often tumor budding (p = 0.012), lymphovascular invasion (p = 0.049), and less harvested lymph nodes (p = 0.042) in comparison to low TP tumors. The results provide first evidence that a high tumor proportion/low stroma proportion is also associated with an adverse prognosis and that this subgroup might be difficult to identify with other classical histopathologic characteristics that are linked to an adverse prognosis.
- Published
- 2020
- Full Text
- View/download PDF
3. Level of interobserver variability estimation as a valuable tool: assessment of tumour budding in colon cancer.
- Author
-
Martin B, Schäfer E, Jakubowicz E, Mayr P, Ihringer R, Anthuber M, Schenkirsch G, Schaller T, and Märkl B
- Subjects
- Humans, Neoplasm Staging methods, Colonic Neoplasms pathology, Observer Variation
- Abstract
Aims: Tumour budding is considered to be a good marker for progression and prognosis in colorectal carcinomas. A uniform classification system has been established recently. The natural element of uncertainty in the practice of human medicine is also exhibited in the assessment of tumour budding. We tested the hypothesis that interobserver variability can be estimated during the assessment process and investigated its potential clinical implication., Methods and Results: Six investigators with different levels of experience could perceive different levels of difficulty (LOD) and estimated different levels of interobserver variability (LOIV) (Li1, lower than average; Li2, average; Li3, higher than average) during the assessment of tumour budding in 244 cases of colon cancer (pT3/4). In total, the LOIV showed following distribution: Li1: 36.1%, Li2: 43.9% and Li3: 20.0%. The LOIV was correlated significantly with the LOD given by the investigator. In total, the agreement rates with the final consensus classification were: Li1: 93.4%, Li2: 78.5% and Li3: 58.4%. The relative risk of disagreement with the final consensus classification was more than six times higher when a case was estimated to have a high rather than a low interobserver variability., Conclusion: Our data show that the investigator can estimate the interobserver variability during the ongoing rating process in pT3/4 colon cancer. The LOIV/LOD seems to be a valuable parameter of the assessment quality. For Li3 cases further measures seem mandatory., (© 2018 John Wiley & Sons Ltd.)
- Published
- 2018
- Full Text
- View/download PDF
4. The prognostic significance of lymph node size in node-positive colon cancer.
- Author
-
Schrembs P, Martin B, Anthuber M, Schenkirsch G, and Märkl B
- Subjects
- Aged, Aged, 80 and over, Colonic Neoplasms metabolism, Colonic Neoplasms surgery, DNA-Binding Proteins metabolism, Female, Humans, Kaplan-Meier Estimate, Lymph Node Excision, Lymph Nodes metabolism, Male, Middle Aged, Mismatch Repair Endonuclease PMS2 metabolism, Multivariate Analysis, Neoplasm Staging, Prognosis, Retrospective Studies, Risk Factors, Colonic Neoplasms pathology, Lymph Nodes pathology, Lymphatic Metastasis pathology
- Abstract
Objectives: To (i) show the outcome benefits of enlarged lymph nodes in node-positive colon cancer cases, as it was shown previously in negative node cases; (ii) disprove the stage migration theory and (iii) list the factors affecting lymph node size and yield., Methods: A retrospective study including 234 node-positive colon cancer cases was scheduled and performed. All recovered lymph nodes (6969) from 234 cases were microscopically examined in regard to (a) lymph node size (b) presence of metastasis (c) extent of intra-nodal metastasis. On the basis of resulting data, a statistical analysis was performed., Results: Metastases occurred in all size categories, though more often in larger lymph nodes. Fifty-one percent of all metastasised nodes were 2 to 6 mm in size. Approximately half of all nodes >10 mm were microscopically free of cancer. Cases with a small lymph node metastasis to lymph node size ratio (MSR) had a better prognosis than others: 85 months (95% CI: 72-97) vs. 67 months (95% CI: 47-88), p <0.001 (mean, overall survival). To differentiate between cases with the same ratio but different absolute lymph nodes sizes, we divided the cases into two groups that differed in their number of moderate to large lymph nodes. The group with more moderate to large lymph nodes showed a clear outcome benefit: 104 months (95% CI: 86-122) vs. 66 months (95% CI: 54-77), p = 0.014 (mean, overall survival)., Conclusions: Metastasised lymph nodes affect all size categories, and large lymph nodes are not always metastasised. The combination of enlarged lymph nodes and a small lymph node metastasis to lymph node size ratio (MSR) is associated with a better prognosis than others. When enlarged lymph nodes were considered as surrogate markers of an effective local immune response due to nodal hyperplasia, the immune system could be seen as the confounder affecting both lymph node size and prognosis. Our results are pointing in this direction and, along with other reasons, are challenging the stage migration theory., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2018
- Full Text
- View/download PDF
5. Interobserver variability in the H&E-based assessment of tumor budding in pT3/4 colon cancer: does it affect the prognostic relevance?
- Author
-
Martin B, Schäfer E, Jakubowicz E, Mayr P, Ihringer R, Anthuber M, Schenkirsch G, Schaller T, and Märkl B
- Subjects
- Adenocarcinoma mortality, Aged, Colonic Neoplasms mortality, Female, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Observer Variation, Prognosis, Proportional Hazards Models, Staining and Labeling, Adenocarcinoma pathology, Colonic Neoplasms pathology, Neoplasm Staging methods, Neoplasm Staging standards
- Abstract
Tumor budding is a mostly accepted adverse prognostic factor in colorectal carcinoma. It is on the cusp of a widespread use after agreement was reached recently on uniform assessment criteria. We investigated whether the interobserver variability has a direct influence on the prognostic relevance in pT3/4 colon cancer in the background of different levels of experience of the investigators. In total, six investigators with different levels of experience evaluated tumor budding on H&E slides in 244 cases with primary diagnosed (2002-2011) colon carcinoma (pT3/4, N+/-, M0). High-grade tumor budding/budding grade 3 (defined as majority assessment among the investigators) was significantly associated with an adverse outcome (overall survival p = 0.03, cancer-specific survival p = 0.08) and the occurrence of distant metastasis (p = 0.009). However, a detailed analysis of the rating results of the individual investigators revealed that only ratings of one investigator (advanced resident) were associated with an adverse outcome (p = 0.01 cancer-specific survival, overall survival p = 0.09, distant metastasis p = 0.002). The results of another investigator (consultant) were significantly associated with distant metastasis (p = 0.007). The kappa values among the investigators have a range between 0.077 and 0.357 (median 0.166). Total agreement of all investigators existed in 109 cases (44.7%). Our results demonstrate that the evaluation of tumor budding on H&E slides in pT3/4 colon cancer goes along with a considerable interobserver variability among investigators of different levels of experience. Furthermore, our results reveal that these findings directly influence the prognostic value.
- Published
- 2018
- Full Text
- View/download PDF
6. A new simple morphology-based risk score is prognostic in stage I/II colon cancers.
- Author
-
Märkl B, Märkl M, Schaller T, Mayr P, Schenkirsch G, Kriening B, and Anthuber M
- Subjects
- Adult, Aged, Aged, 80 and over, Chemotherapy, Adjuvant, Colonic Neoplasms mortality, Colonic Neoplasms therapy, Female, Histocytochemistry, Humans, Immunohistochemistry, Lymph Nodes pathology, Male, Middle Aged, Neoplasm Grading, Neoplasm Invasiveness, Neoplasm Staging, Patient Outcome Assessment, Prognosis, Risk Assessment methods, Survival Analysis, Colonic Neoplasms diagnosis
- Abstract
A portion of stage I/II colon cancers (10-20%) exhibit an adverse clinical course. The administration of adjuvant chemotherapy is recommended only in certain high-risk situations. However, these risk factors recently failed to predict benefit from adjuvant therapy. We composed a new morphology-based risk score that includes pT1/2 versus 3/4 stage, vascular or lymphovascular invasion, invasion type according to Jass, tumor budding and paucity (less than two) of lymph nodes larger than 5 mm. The occurrence of each of these factors accounts for one point in the score (Range 0-5). This score was evaluated in a retrospective study that included 301 cases. The overall survival differed significantly between the three groups with median survival times of 103, 90, and 48 months, respectively. Multivariable analysis revealed morphology-based risk-high risk and low risk-as the sole independent factors for the prediction of death. Morphology-based risk scoring was superior to microsatellite status and NCCN risk stratification. This method identifies a group of patients that comprises 18% of the stage II cases with an adverse clinical course. Further studies are necessary to confirm its prognostic value and the possible therapeutic consequences., (© 2016 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.)
- Published
- 2016
- Full Text
- View/download PDF
7. Number of Intratumoral T Lymphocytes Is Associated With Lymph Node Size, Lymph Node Harvest, and Outcome in Node-Negative Colon Cancer.
- Author
-
Märkl B, Wieberneit J, Kretsinger H, Mayr P, Anthuber M, Arnholdt HM, and Schenkirsch G
- Subjects
- Aged, Area Under Curve, Colonic Neoplasms mortality, Colonic Neoplasms pathology, Female, Humans, Image Processing, Computer-Assisted, Immunohistochemistry, Kaplan-Meier Estimate, Male, Middle Aged, Prognosis, ROC Curve, Retrospective Studies, Sensitivity and Specificity, Colonic Neoplasms immunology, Lymph Nodes pathology, Lymphocytes, Tumor-Infiltrating pathology, T-Lymphocytes pathology
- Abstract
Objectives: We postulated that lymph node (LN) harvest and LN size are influenced by immunologic effects., Methods: To investigate this hypothesis, we performed a retrospective analysis of 170 node-negative colon cancer cases to evaluate the density of intratumoral T lymphocytes (ITLs). CD3- and CD8-positive T cells were counted using a digital system., Results: The ITL density was significantly increased in cases with sufficient LN harvest and high numbers of LNs larger than 5 mm (LN5). High ITL numbers were associated with improved cancer-specific survival. The analysis of the immune score revealed a significantly different cancer-specific outcome (P = .024), with no cancer-related death in the group with the highest score. The immune score and tumor budding were independently prognostic., Conclusions: ITL density is independently prognostic and associated with LN harvest and LN size. The immune response is very likely the true explanation for the known prognostic effect of the LN harvest in colon cancer., (© American Society for Clinical Pathology, 2016. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2016
- Full Text
- View/download PDF
8. Lymph node hypoplasia is associated with adverse outcomes in node-negative colon cancer using advanced lymph node dissection methods.
- Author
-
Mayr P, Aumann G, Schaller T, Schenkirsch G, Anthuber M, and Märkl B
- Subjects
- Aged, Aged, 80 and over, Cohort Studies, Colonic Neoplasms surgery, Female, Humans, Male, Methylene Blue, Middle Aged, Neoplasm Invasiveness, Reproducibility of Results, Survival Analysis, Survival Rate, Colonic Neoplasms mortality, Colonic Neoplasms pathology, Lymph Node Excision, Lymph Nodes pathology
- Abstract
Purpose: Lymph node size as a prognostic parameter has not been investigated well in the past. Recent data, however, have indicated that this parameter could be even more important than the lymph node count., Methods: Based on the results of earlier studies, we analyzed the lymph node size and number of node-negative colon cancer patients with regard to survival. Data from 115 node-negative cases of colon cancer were analyzed. Lymph nodes with diameters ≤5 mm were defined as small, and all other lymph nodes were classified as intermediate/large in size and labeled LN5. All of the cases were categorized according to the number of LN5s. The LN5 very low (LN5vl) group included cases with less than two LN5s. All of the other cases were assigned to the LN5 low/high (LN5l/h) group., Results: The overall survival analysis revealed significantly worse outcomes for the LN5vl group, with a mean survival of 34 months compared to the LN5l/h group, with a mean survival of 40 months (P = 0.022). After adjusting for the pT1/2 and pT3/4 stages, we still found a significant outcome difference (P = 0.012). Multivariate analysis identified LN5vl and T-stage as being independently correlated with the outcome. The vast majority of LN5vl cases (91 %) were located in the left colon. The location itself, however, was not prognostic (P = 0.478)., Conclusion: LN5 count, as a marker of immune response, could be shown as being prognostic in node-negative colon cancer. Patients with low LN5 counts showed poor outcomes. These patients could perhaps profit from adjuvant chemotherapy.
- Published
- 2016
- Full Text
- View/download PDF
9. The clinical significance of lymph node size in colon cancer.
- Author
-
Märkl B, Rößle J, Arnholdt HM, Schaller T, Krammer I, Cacchi C, Jähnig H, Schenkirsch G, Spatz H, and Anthuber M
- Subjects
- Adenocarcinoma mortality, Adenocarcinoma surgery, Aged, Cohort Studies, Colonic Neoplasms mortality, Colonic Neoplasms surgery, Female, Germany epidemiology, Humans, Lymph Node Excision, Lymphatic Metastasis, Male, Neoplasm Staging, Predictive Value of Tests, Prognosis, ROC Curve, Sentinel Lymph Node Biopsy, Survival Rate, Adenocarcinoma secondary, Colonic Neoplasms pathology, Lymph Nodes pathology
- Abstract
To date, the clinical value of lymph node size in colon cancer has been investigated only in a few studies. Only in radiological diagnosis is lymph node size routinely recognized, and nodes ≥10 mm in diameter are considered pathologic. However, the few studies regarding this topic suggest that lymph node size is not a reliable indicator of metastatic disease. Moreover, we hypothesized that increasing lymph node size is associated with favorable outcome. By performing a morphometric study, we investigated the clinical significance of lymph node size in colon cancer in terms of metastatic disease and prognosis. A cohort of 237 cases with excellent lymph node harvest (mean lymph node count: 33±17) was used. The size distribution in node-positive and -negative cases was almost identical. In all, 151 out of the 305 metastases detected (49.5%) were found in lymph nodes with diameters ≤5 mm. Only 25% of lymph nodes >10 mm showed metastases. Minute lymph nodes ≤1 mm were involved only very rarely (2 of 81 cases). In 67% of the cases, the largest positive lymph node was <10 mm. The prognostic relevance of lymph node size was investigated in a subset of 115 stage I/II cases. The occurrence of ≥7 lymph nodes that were >5 mm in diameter was significantly associated with better overall survival. Our data show that lymph node size is not a suitable factor for preoperative lymph node staging. Minute lymph nodes have virtually no role in correct histopathological lymph node staging. Finally, large lymph nodes in stage I/II disease might indicate a favorable outcome.
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.